Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00733512 · ClinicalTrials.gov registry record

Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL)

A clinical trial of Cataract, sponsored by Alcon Research.

Completed
Registry status
146
Enrollment target
1
Study location

NCT00733512 is a study of Cataract that has completed, run by Alcon Research. The registered enrollment target is 146 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00733512, a study of Cataract, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
146 participants
Enrollment target
1
Study location

Study Summary

To collect visual outcome data post AcrySof ReSTOR Aspheric +4 implantation from surgeons throughout the United States.

Conditions Studied

Interventions

  • DEVICE ReSTOR

Study Locations (1)

Texas

  • Alcon Call Center for Trial Locations - Fort Worth

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2007-06
Est. Completion 2008-03

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT00733512

The ClinicalTrials.gov registry entry for NCT00733512 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (36% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which ReSTOR is the first listed.

NCT00733512 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00733512 about?

NCT00733512 is a clinical study titled "Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL)". To collect visual outcome data post AcrySof ReSTOR Aspheric +4 implantation from surgeons throughout the United States.

What is the current status of trial NCT00733512?

This trial is currently completed. The enrollment target is 146 participants. The study started on 2007-06. Estimated completion is 2008-03.

What conditions does trial NCT00733512 study?

This clinical trial studies the following conditions: Cataract.

What interventions are being tested in trial NCT00733512?

The interventions under investigation include: ReSTOR (DEVICE).

Who is sponsoring clinical trial NCT00733512?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00733512 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.